Adherium

Address:
Level 2, 204 Quay Street
Auckland 1010
NZ
New Zealand

Adherium articles

Displaying 1 - 1 of 1

SmartTouch for Symbicort inhaler cleared by FDA

SmartTouch for Symbicort inhaler cleared by FDA
Adherium has announced U.S. FDA 510(K) clearance for its new SmartTouch for Symbicort inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler. The SmartTouch for Symbicort is a device installed onto a patient’s inhaler to monitor and encourage medication adherence as part of a self-management plan. It is the latest product to be added to Adherium’s product portfolio to assist patients, who suffer from respiratory conditions such as asthma and COPD, with adherence.
5th September 2017


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Medical Japan 2018
21st February 2018
Japan INTEX Osaka
Med-Tech Innovation Expo 2018
25th April 2018
United Kingdom Ricoh Arena, Coventry